Patent · US Active

Ligands

US7982038B2 · kind B2 · utility

0Cited by

2References

3Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Peter Dorff · Wilmington, US
John C. Gordon · White Rock, US
John Richard Heys · Malvern, US
Richard Keith · Wilmington, US
Dennis McCarthy · Wilmington, US
Mark Smith · Cleveland, US
Eifion Phillips · Boothwyn, US

Key dates

Filing date	Sep 24, 2004
Grant date	Jul 19, 2011
Priority date	—
Expiry date	Jan 29, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A radioactive compound having the formula:and pharmaceutically-acceptable salts thereof, wherein R1 and Ar are as defined in the specification, enantiomers, in vivo-hydrolysable precursors, pharmaceutical compositions and formulations containing them, methods of using them to treat diseases and conditions either alone or in combination with other therapeutically-active compounds or substances, processes and intermediates used to prepare them and uses of them for diagnostic and analytic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.